Logistics Process of Pharmacy Companies
Logistics Process of Pharmacy Companies
MEMBERS
AKSHAY SURVE
Introduction
Logistics is the management of the flow of resources between the point of origin and the point of consumption in order to meet some requirements. For example, of customers or corporations. The resources managed in logistics can include physical items, such as food, materials, equipment, liquids, and staff, as well as abstract items, such as time, information, particles, and energy.
Definition
The task of coordinating material flow and information flow across the supply chain.
LOGISTICS PROCESS
A supply chain is a group of partners who collectively convert a basic commodity (upstream) into a finished product (downstream) that is valued by end-customers, and who manage returns at each stage. Definition
Planning and controlling all of the processes that link partners in a supply chain together in order to serve needs of the end-customer.
PHARMACY
Pharmacy is the science and technique of preparing and dispensing drugs and medicines. It is a health profession that links the health sciences with the chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs.
CIPLA
Cipla Limited is a pharmaceutical company based in Mumbai, India. Founded by nationalist Indian scientist Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories in 1935, Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions.
PROCUREMENT
MANUFACTURING
WAREHOUSING
TRANSPORTATION
DISTRIBUTION
CUSTOMERS
LABORATORIES
RETAILERS
MEDICAL STORES
Supplier Materials
Biologic suppliers
Chemicals Farm products (plants, eggs, animals, animal by-products) Laboratory animals Growth media, cell cultures Pathogens Proteins Test organisms
Non-biologic suppliers
Equipment Computers, software Databases (e.g., target molecules, DNA sequences) Clinical trial supplies Clinical trial subject population information
13
Grouping plants with standard equipment and processes geared to specific product types (e.g., dry products, freeze-dried, parenteral) Redundant facilities (security, shifting of work between plants) Global demand management center Centralized ownership of all forecasting tools and databases Use of ERP web-enabled global planning capabilities
14
WAREHOUSING
Cipla uses the latest in pharmaceutical technology to funnel seven decades of experiences into one capsule that cures, one drop that defends and one puff that protects. They explore every drug to its last particle and instill safe and
sure healing to create one dose of confidence.
Identical copies
Least common Made with same ingredients, formulas and packaging but not by the same manufacturer High-quality packaging and labeling; very convincing appearance Little or no active ingredients Authentic drugs that have passed their expiration dates Distributed by foreign sources.
Look-alikes:
Re-labels:
16
Often turn to secondary distribution channels when manufacturers or major distributors cannot supply critical drugs when needed
Drugs often stockpiled by secondary distributors for economic reasons Drug markups can be 500 1,000% during shortages (e.g., a vial of flu vaccine purchased by a wholesaler for $23.65 was resold to an end-user for $147 in 2003)
Alliances of pharmacies, hospitals and other healthcare systems Leverage buying power to obtain manufacturer discounts
Temperature-sensitive products, when diverted, are often not kept at the appropriate temperatures Retailers attribute 48 percent of pharmaceutical inventory loss to employee theft Emerging requirements for secondary distributors to provide a drug pedigree that can be tracked back to the original source (manufacturer)
Clear chain of custody Cost of maintaining custodial information will fall on manufacturers
17
CONCLUSION
THANKYOU